Metis Global Partners’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-11,521
| Closed | -$871K | – | 725 |
|
|
2026
Q1 | $871K | Sell |
11,521
-994
| -8% | -$74.7K | 0.02% | 472 |
|
|
2025
Q4 | $932K | Buy |
12,515
+5,013
| +67% | +$366K | 0.02% | 474 |
|
|
2025
Q3 | $506K | Sell |
7,502
-525
| -7% | -$34.9K | 0.01% | 598 |
|
|
2025
Q2 | $523K | Sell |
8,027
-11,274
| -58% | -$676K | 0.01% | 589 |
|
|
2025
Q1 | $1.19M | Buy |
19,301
+2,981
| +18% | +$198K | 0.03% | 427 |
|
|
2024
Q4 | $1.18M | Buy |
16,320
+665
| +4% | +$52K | 0.04% | 401 |
|
|
2024
Q3 | $1.28M | Buy |
15,655
+623
| +4% | +$49.8K | 0.04% | 392 |
|
|
2024
Q2 | $1.12M | Buy |
15,032
+400
| +3% | +$30K | 0.04% | 392 |
|
|
2024
Q1 | $1.14M | Buy |
14,632
+250
| +2% | +$18.6K | 0.04% | 395 |
|
|
2023
Q4 | $1.03M | Sell |
14,382
-230
| -2% | -$16K | 0.04% | 400 |
|
|
2023
Q3 | $1.01M | Buy |
14,612
+1,905
| +15% | +$144K | 0.05% | 376 |
|
|
2023
Q2 | $1.03M | Buy |
12,707
+624
| +5% | +$51K | 0.06% | 360 |
|
|
2023
Q1 | $975K | Buy |
12,083
+2,008
| +20% | +$162K | 0.06% | 339 |
|
|
2022
Q4 | $754K | Buy |
10,075
+4,860
| +93% | +$346K | 0.07% | 326 |
|
|
2022
Q3 | $336K | Buy |
5,215
+546
| +12% | +$37.8K | 0.05% | 383 |
|
|
2022
Q2 | $324K | Buy |
4,669
+668
| +17% | +$49.6K | 0.05% | 396 |
|
|
2022
Q1 | $307K | Buy |
+4,001
| New | +$288K | 0.04% | 413 |
|
Other funds holding HOLX
Metis Global Partners's HOLX Position: Q2 2026 in Review
Metis Global Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 11,521 shares — an estimated $871K sold.
Metis Global Partners first reported a position in HOLX in Q1 2022 and held it in 17 quarters. The position peaked at $1.28M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Metis Global Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Metis Global Partners sold 11,521 Hologic shares in Q2 2026, an estimated $871K.
- Metis Global Partners first reported a position in Hologic in Q1 2022 and held it in 17 quarters.
- Metis Global Partners's Hologic position peaked at $1.28M in Q3 2024.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.